Biomarkers of Duchenne muscular dystrophy: current findings
CAK Szigyarto, P Spitali - Degenerative neurological and …, 2018 - Taylor & Francis
Numerous biomarkers have been unveiled in the rapidly evolving biomarker discovery field,
with an aim to improve the clinical management of disorders. In rare diseases, such as …
with an aim to improve the clinical management of disorders. In rare diseases, such as …
Muscle MRI in patients with dysferlinopathy: pattern recognition and implications for clinical trials
J Diaz-Manera, R Fernandez-Torron… - Journal of Neurology …, 2018 - jnnp.bmj.com
Background and objective Dysferlinopathies are a group of muscle disorders caused by
mutations in the DYSF gene. Previous muscle imaging studies describe a selective pattern …
mutations in the DYSF gene. Previous muscle imaging studies describe a selective pattern …
Skeletal muscle magnetic resonance biomarkers correlate with function and sentinel events in Duchenne muscular dystrophy
Objective To provide evidence for quantitative magnetic resonance (qMR) biomarkers in
Duchenne muscular dystrophy by investigating the relationship between qMR measures of …
Duchenne muscular dystrophy by investigating the relationship between qMR measures of …
Longitudinal timed function tests in Duchenne muscular dystrophy: ImagingDMD cohort natural history
H Arora, RJ Willcocks, DJ Lott, AT Harrington… - Muscle & …, 2018 - Wiley Online Library
Introduction: Tests of ambulatory function are common clinical trial endpoints in Duchenne
muscular dystrophy (DMD). Using these tests, the ImagingDMD study has generated a large …
muscular dystrophy (DMD). Using these tests, the ImagingDMD study has generated a large …
1H NMRS of carnosine combined with 31P NMRS to better characterize skeletal muscle pH dysregulation in Duchenne muscular dystrophy
H Reyngoudt, S Turk, PG Carlier - NMR in Biomedicine, 2018 - Wiley Online Library
In recent years, quantitative nuclear magnetic resonance imaging and spectroscopy (NMRI
and NMRS) have been used more systematically as outcome measures in natural history …
and NMRS) have been used more systematically as outcome measures in natural history …
MR imaging of the musculoskeletal system using ultrahigh field (7T) MR imaging
H Alizai, G Chang, RR Regatte - PET clinics, 2018 - pet.theclinics.com
In vivo musculoskeletal MR imaging plays a critical role in the modern medical practice. The
excellent soft tissue contrast and multiplanar and multiparametric capabilities of MR imaging …
excellent soft tissue contrast and multiplanar and multiparametric capabilities of MR imaging …
Human Adipose-Derived CD146+ Stem Cells Increase Life Span of a Muscular Dystrophy Mouse Model More Efficiently than Mesenchymal Stromal Cells
JP Gomes, GC Coatti, MC Valadares… - DNA and cell …, 2018 - liebertpub.com
Duchenne muscular dystrophy is the most common and severe form of progressive
muscular dystrophy. Previous results showed an increased survival in double knockout mice …
muscular dystrophy. Previous results showed an increased survival in double knockout mice …
Multivoxel proton magnetic resonance spectroscopy in facioscapulohumeral muscular dystrophy
Introduction: Facioscapulohumeral muscular dystrophy (FSHD) is a hereditary disorder that
causes progressive muscle wasting. This study evaluates the use of proton magnetic …
causes progressive muscle wasting. This study evaluates the use of proton magnetic …
Multi-parametric MR shows increased T2 heterogeneity in fat infiltrated muscles in Becker Muscular Dystrophy
Quantitative MR is increasingly used to assess muscle damage in muscular dystrophies,
including BMD. Early markers that reflect changes in muscle tissue are becoming …
including BMD. Early markers that reflect changes in muscle tissue are becoming …
[PDF][PDF] Pediatric Imaging• Original Research
Z Li, H Zeng, C Han - 2018 - academia.edu
D uchenne muscular dystrophy (DMD) is the most common X-linked recessive muscular
dysa trophy [1], having an incidence of 1 in 3500 male births. The onset of disease ranges …
dysa trophy [1], having an incidence of 1 in 3500 male births. The onset of disease ranges …